Influence of Acute Exposure to High Altitude on Basal and Postprandial Plasma Levels of Gastroenteropancreatic Peptides

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Riepl, Rudolf L ^a   Fischer, Rainald ^b   Hautmann, Hubert ^c   Hartmann, Gunther ^d   Müller, Timo D ^c   Tschöp, Matthias ^c   Toepfer, Marcell ^e   Otto, Bärbel ^b  

^a Kreiskrankenhaus Erding   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e General Practice   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GASTRIN; GASTROENTEROPANCREATIC PEPTIDE; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; MOTILIN; NEUROTENSIN; PANCREAS POLYPEPTIDE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACUTE MOUNTAIN SICKNESS; ALTITUDE DISEASE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; ENVIRONMENTAL EXPOSURE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; MALE; NAUSEA AND VOMITING; OXYGEN SATURATION; OXYGEN TENSION; PEPTIDE ANALYSIS; POSTPRANDIAL STATE; RADIOIMMUNOASSAY;

ALTITUDE; CHOLECYSTOKININ; ENVIRONMENTAL EXPOSURE; GASTRINS; HUMANS; MOTILIN; PANCREATIC POLYPEPTIDE; PEPTIDES; POSTPRANDIAL PERIOD; RADIOIMMUNOASSAY;

EID: 84866082202     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044445     Document Type: Article

References (42)

1. Basnyat B, Murdoch DR, (2003) High-altitude illness. Lancet 361: 1967-1974.
2. Hackett PH, Roach RC, (2001) High altitude illness. New Engl J Med 345: 107-114.
3. Daniel EE (1991) Neuropeptide function in the gastrointestinal tract. CRC Press, Boca Raton, Boston, Ann Arbor.
4. Walsh JH, Dockray GJ (1994) Gut peptides- Biochemistry and Physiology. Raven Press, New York.
5. Westerterp KR, Kayser B, (2006) Body mass regulation at altitude. Eur J Gastroenterol Hepatol 18: 1-3.
6. Lippl FJ, Neubauer S, Schipfer S, Lichter N, Tufman A, et al. (2010) Hypobaric hypoxia causes body weight reduction in obese subjects. Obesity 18: 675-681.
7. Westerterp-Plantenga MS, Westerterp KR, Rubbens M, Verwegen CR, Richelet JP, et al. (1999) Appetite at "high altitude" [Operation Everest III (Comex-́97)]: a simulated ascent of Mount Everest. J Appl Physiol. 87: 391-399.
8. Bailey DM, Davies B, Milledge JS, Richards M, Williams SR, et al. (2000) Elevated plasma cholecystokinin at high altitude: metabolic implications for the anorexia of acute mountain sickness. High Alt Med Biol 1: 9-23.
9. Bailey DM, Davies B, Castell LM, Newsholme EA, Calam J, (2001) Physical exercise and normobaric hypoxia: independent modulators of peripheral cholecystokinin metabolism in man. J Appl Physiol 90: 105-113.
10. Benso A, Broglio F, Aimaretti G, Lucatello B, Lanfranco F, et al. (2007) Endocrine and metabolic responses to extreme altitude and physical exercise in climbers. Eur J Endocrinol 157: 733-740.
11. Gritti I, Banfi G, Roi GS, (2000) Pepsinogens: physiology, pharmacology pathophysiology and exercise. Pharmacol Res 41: 265-281.
12. Jó N, Garcia O, Jara F, Garmendia A, Nago R, et al. (1987) Serum gastrin and gastric acid secretion at high altitude. Horm Metab Res 19: 182-183.
13. Jó N, Garcia O, Garcia R, Jara R, Woll P, et al. (1990) Achlorhydria, blood gastrin and normal gastric mucosa in high altitude subjects. Rev Gastroenterologia Peru 10: 9-13.
14. Knudtzon J, Myhre K, Rasch W, Neslein IL, Bogsnes A, et al. (1989) Reduced systolic blood pressure elevations during maximum exercise at simulated altitudes. Aviat Space Envir Med 60: 1072-1076.
15. Shen D, Wang Y, (1998) Changes of plasma level of neurotensin, somatostatin, and dynorphin A in pilots under acute hypoxia. Military Medicine 163: 120-121.
16. Shukla V, Singh SN, Vats P, Singh VK, Singh SB, et al. (2005) Ghrelin and leptin levels of sojourners and acclimatized lowlanders at high altitude. Nutr Neurosci 8: 161-165.
17. Chaiban JT, Bitar FF, Azar ST, (2008) Effect of chronic hypoxia on leptin, insulin, adiponectin, and ghrelin. Metabolism 57: 1019-1022.
18. Li X, Lu WC, Zhu YJ, (1990) The relation of vasoactive intestinal peptide and acute hypoxia. Chinese J Internal Med 29: 8-10.
19. Mouats A, Guilloteau P, Chayvialle JA, Toullec R, Bernarde C, et al. (1990) Effect of hypoxia on plasma concentrations of gastrin and gastric inhibitory polypeptide (GIP) in newborn calves. Reprod Nutr Develop Suppl. 2: 219s-220s.
20. Poncet L, Denoroy L, Dalmaz Y, Péquignot J-M, Jouvet M, (1994) Chronic hypoxia affects peripheral and central vasoactive intestinal peptide-like immunoreactivity in the rat. Neurosci Letters 176: 1-4.
21. Sakio H, Okuda C, Yoshida Y, Said SI, (1980) Release of vasoactive intestinal polypeptide during acute hypoxia and acute respiratory acidosis. Respir Circul 28: 1161-1166.
22. Yang CM, Chen Y, Mao GP, Ma LN, Wang Z, et al. (2006) Effects of acute hypobaric hypoxia on gastric emptying and intestinal propulsion: experiments in rats. Zhonghua Yi Xue Za Zhi 86: 2391-2394.
23. Hartmann G, Tschoep M, Fischer R, Bidlingmaier C, Riepl R, et al. (2000) High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 12: 246-252.
24. Roach RC, Bärtsch P, Hackett PH, Ölz O (1993) The Lake Louise acute mountain sickness scoring system. In: Hypoxia and molecular medicine. Hypoxia Symposium Lake Louise. JR Sutton, CS Houston and G Coates, eds., Queen City Press, Burlington, Vt; 272-274.
25. Riepl RL, Fiedler F, Kowalski Ch, Teufel J, Lehnert P, (1996) Exocrine pancreatic secretion and plasma levels of cholecystokinin, pancreatic polypeptide, and somatostatin after single and combined intraduodenal application of different bile salts in man. Ital J Gastroenterol 28: 421-429.
26. Riepl RL, Reichardt B, Rauscher J, Tzavella K, Teufel J, et al. (1996) Mediators of exocrine pancreatic secretion induced by intraduodenal application of bile and taurodeoxycholate in man. Eur J Med Res 2: 23-29.
27. Riepl RL, Lehnert P, Scharl A, Hempen I, Fiedler F, et al. (1990) Effect of intraduodenal bile and Na-taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of secretin, pancreatic polypeptide, and gastrin in man. Scand J Gastroenterol 25: 45-53.
28. Riepl RL, Fiedler F, Teufel J, Lehnert P, (1994) Effect of intraduodenal bile and taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of vasoactive intestinal polypeptide and somatostatin in man. Pancreas 9: 109-116.
29. Liddle RA (1994) Cholecystokinin. In: Gut peptides - Biochemistry and Physiology. JH Walsh and GJ Dockray, eds. Raven Press, New York; 175-216.
30. Wren AM, Bloom SR, (2007) Gut hormones and appetite control. Gastroenterology 132: 2116-2130.
31. Jó N, Garcia O, Pacora P, Garcia R, Jara R, et al. (1992) Sensitivity of the parietal cell to the effect of pentagastrin in men living at high altitude. Rev Esp Enferm Dig 81: 99-102.
32. Poitras P (1994) Motilin. In: Gut peptides - Biochemistry and Physiology. JH Walsh and GJ Dockray, eds. Raven Press, New York; 261-304.
33. Schwartz TW, (1983) Pancreatic polypeptide: A hormone under vagal control. Gastroenterology 85: 1411-1425.
34. Mannon P, Taylor IL (1994) The pancreatic polypeptide family. In: Gut peptides - Biochemistry and Physiology. JH Walsh and GJ Dockray, eds. Raven Press, New York; 341-370.
35. Shulkes A (1994) Neurotensin. In: Gut peptides - Biochemistry and Physiology. JH Walsh and GJ Dockray, eds. Raven Press, New York; 371-388.
36. Dockray GJ (1994) Vasoactive intestinal peptide and related peptides. In: Gut peptides - Biochemistry and Physiology. JH Walsh and GJ Dockray, eds. Raven Press, New York; 175-216.
37. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, et al. (2001) Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50: 227-232.
38. Tschöp M, Smiley DL, Heiman ML, (2000) Ghrelin induces adipositiy in rodents. Nature 407: 908-913.
39. Tschöp M, Morrison KM, (2001) Weight loss at high alitude. Adv Exp Med Biol 502: 237-247.
40. Tschöp M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, et al. (2001) Postprandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24: RC19-21.
41. Materia A, Jaffe BM, Modlin IM, Sank A, Albert D, (1981) Effect of methionine-enkephalin and naloxone on bombesin-stimulated gastric acid secretion, gastrin, and pancreatic polypeptide release in the dog. Ann Surg 196: 48-52.
42. Riepl RL, Reichardt B, Auernhammer CJ, Beier G, Schopohl J, et al. (1996) Suppression of vagus-mediated pancreatic polypeptide release by the μ-opiate receptor agonist loperamide. Brit J Clin Pharmacol 42: 371-377.